Subscribe To Print Edition About The Tribune Code Of Ethics Download App Advertise with us Classifieds
search-icon-img
  • ftr-facebook
  • ftr-instagram
  • ftr-instagram
search-icon-img
Advertisement

Himachal pharma units using fake companies to market narcotic drugs

Ambika SharmaTribune News ServiceSolan, June 8 Fake marketing firms appear to have become a convenient ploy to facilitate nefarious sale of narcotic and psychotropic drugs by the pharmaceutical units located in Sirmaur district of Himachal Pradesh. 60 lakh pills seized...
  • fb
  • twitter
  • whatsapp
  • whatsapp
Advertisement

Ambika Sharma
Tribune News Service
Solan, June 8

Fake marketing firms appear to have become a convenient ploy to facilitate nefarious sale of narcotic and psychotropic drugs by the pharmaceutical units located in Sirmaur district of Himachal Pradesh.

60 lakh pills seized

  • The Punjab Police seized 30.2 lakh tramadol tablets on May 28 from Paonta Sahib-based Unique Formulations
  • The Kala Amb police seized 30.10 lakh tablets, 226 kg tramadol powder and over 1,000 wrappers of two marketing firms from Orison Pharmaceutical on June 2
  • SP, Sirmaur, KC Sharma says a scrutiny of the firms’ records is underway to crack the case

Two pharmaceutical firms located at Kala Amb and Paonta Sahib were booked under the NDPS Act for forgery, cheating and criminal conspiracy during the last fortnight. The move came after “tramadol” tablets worth crores manufactured by these firms were seized by the Punjab Police. Investigations reveal that the tablets seized from Kala Amb-based Orison Pharma recently were marketed by two firms that did not exist at the addresses mentioned on the drug wrappers. These firms were New Healthcare, Sahibabad (Ahmedabad), and PP Pharma, Mumbai.

Advertisement

In case of the Paonta Sahib-based Unique Formulations, marketing firm PB Pharmaceuticals, New Delhi, did not exist at the given address.

The Drug Licensing Authority has cancelled the licence of Unique Formulation after it failed to respond to a show-cause notice while the case of Orison Pharma is being examined based on its reply. Manufacturing of drugs has been put on hold at both units. As per an amendment made to the Drugs and Cosmetics Act, which became applicable from March 1, no marketer shall undertake sale or distribution of any drug manufactured by a manufacturer by labelling his name on that without an agreement. A marketer would also be held responsible for the quality of that drug and other regulatory compliances. State Drugs Controller Navneet Marwaha said a team of officials was probing all such firms to ensure that the new amendment was adhered to in letter and spirit.

Advertisement

SP, Sirmaur, KC Sharma said a scrutiny of the firms’ records was underway.

Advertisement
Advertisement
Advertisement
Advertisement
tlbr_img1 Home tlbr_img2 Opinion tlbr_img3 Classifieds tlbr_img4 Videos tlbr_img5 E-Paper